News
Hyderabad-based Natco Pharma has filed a lawsuit against Danish drugmaker Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy (semaglutide), before the Delhi High Court.
A steep decline in Ozempic maker Novo Nordisk’s share price has sent consumer confidence ... has suffered amid worries over ...
What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.
Telehealth company Ro has enlisted former tennis player Serena Williams as a celebrity patient ambassador for its weight-loss treatments, it said on Thursday. Read more at straitstimes.com. Read more ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
She admitted she turned to the controversial jab after gaining two stone in weight following the death of her best friend Femi in 2024.
Serena Williams has joined telehealth company Ro as a celebrity ambassador for their weight-loss treatments. Williams will star in ads for GLP-1 medications and share her health journey post-pregnancy ...
The United States and European Union on Thursday released new details of their trade framework, providing clarity on tariffs for sectors including pharmaceuticals, semiconductors, and autos after ...
3hon MSN
Layoffs loom at weight loss drug Wegovy's maker Novo Nordisk as slowing sales threaten job cuts
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...
It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about ... For starters, it’s no longer the only game in town, following the approval of Eli Lilly’s tirzepatide for obesity ...
Demand for Novo Nordisk A/S’s weight-loss blockbuster Wegovy is getting a boost in the UK from an unexpected corner: ...
In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results